Browsing: Obesity

Breaking the cycle between these two health conditions requires addressing underlying hormonal and metabolic changes, often through a combination of lifestyle changes, medications, and, for some…

Oral Semaglutide (Wegovy)Oral semaglutide (Wegovy) was approved by the U.S. Food and Drug Administration (FDA) in December 2025 as a treatment for weight loss in people with…

Rapid weight loss with GLP‑1 medications affects more than just body fat; it also reduces fat-free mass, including muscle, bone, connective tissue, and fluids. Typically, about…